SERTOLI-CELL-ONLY SYNDROME

This adverse event was reported 15 times

These drugs are most commonly taken by patients reporting SERTOLI-CELL-ONLY SYNDROME:

# Drug Count
0 BUSULFAN 9
1 CYCLOPHOSPHAMIDE 9
2 CYCLOPHOSPHAMIDE FOR INJECTION 9
3 CYCLOPHOSPHAMIDE INJECTION, SOLUTION 9
4 CYCLOSPORINE 6
5 CYTARABINE 6
6 METHOTREXATE SODIUM 6
7 METHOTREXATE 5
8 CARMUSTINE 4
9 ETOPOSIDE 3
See all common drugs associated with SERTOLI-CELL-ONLY SYNDROME

SERTOLI-CELL-ONLY SYNDROME is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 IDARUBICIN HYDROCHLORIDE 1 0.0009
1 CARMUSTINE 4 0.0008
2 BUSULFAN 9 0.0006
3 MELPHALAN HYDROCHLORIDE 3 0.0001
4 CYTARABINE 6 0.0001
5 CYCLOSPORINE 6 0.0001
6 CYCLOPHOSPHAMIDE FOR INJECTION 9 0.0001
7 CYCLOPHOSPHAMIDE 9 0.0001
8 ETOPOSIDE 3 0.0000
9 FINASTERIDE 2 0.0000
See all drugs enriched for association with SERTOLI-CELL-ONLY SYNDROME

SERTOLI-CELL-ONLY SYNDROME is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Alkylating Drug [EPC] 13 0.0001
1 Calcineurin Inhibitor Immunosuppressant [EPC] 6 0.0000
2 Topoisomerase Inhibitor [EPC] 3 0.0000
3 Nucleoside Metabolic Inhibitor [EPC] 6 0.0000
4 5-alpha Reductase Inhibitor [EPC] 2 0.0000
5 Folate Analog Metabolic Inhibitor [EPC] 5 0.0000
See all drug classes enriched for association with SERTOLI-CELL-ONLY SYNDROME